JAZZ
Jazz Pharmaceuticals plc Common Stock (Ireland)Stock · Health Care$245.84−$3.11 (-1.25%)as of market close, Aug 13, 2026
☾ After hours:$245.85+0.00%3:59 PM ET
JAZZ — Jazz Pharmaceuticals plc Common Stock (Ireland) stock price, chart and key statistics
Key stats#
Price data
- Price
- $245.84
- Change YTD
- +44.61%
- Market cap
- 16B
- Enterprise value
- 18.2B
- Shares outstanding
- 64.9M
- 52W low
- $112.49
- 52W high
- $265.05
- From 52W high
- -7.25%
- From 52W low
- +118.54%
- 52W range
- 87%
- Beta
- 0.36
Volume
- Rel volume
- 0.46×
- 30D volume
- 790.1K
- 30D $ vol
- 198.2M
Fundamentals
- Sales (ttm)
- 4.6B
- Sales/share
- $70.88
- EPS (ttm)
- $14.58
- FCF (ttm)
- 1.6B
- FCF/share
- $24.51
- Book value/share
- $73.97
- Net margin
- 20.45%
- ROE
- 19.59%
- ROA
- 8.49%
- Debt / equity
- 0.69×
- Current ratio
- 1.78
Growth (CAGR, ttm) · 10Y
- Sales
- +12.65%
- Net income
- +10.05%
- FCF
- +11.03%
- Shares
- +0.70%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +9.71%
- Sales/share
- +11.86%
- FCF/share
- +10.26%
- Book value/share
- +9.53%
- Price
- +6.05%
- Total return
- +6.05%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- 16.9×
- 17.8×
- Fwd P/E
- 9.6×
- 3.5×
- 3.3×
- 10.0×
- EV/EBITDA (fy)
- 18.9×
- EV/Sales (ttm)
- 4.0×
- 9.97%
- -7.02%
- -7.02%
- 0.00%
- 0.00%
Vs own 10Y history
- P/E
- 30th
- P/OI
- 58th
- P/S
- 56th
- P/B
- 80th
- P/FCF
- 52nd
Bar = where today's multiple sits in JAZZ's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return#
1D
-1.25%
1W
-4.21%
1M
+2.72%
3M
+5.82%
YTD
+44.61%
1Y
+116.92%
5Y
+65.56%
Financial statements
Open full JAZZ financials →Related Health Care#
1MJazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ) trades at $245.84 with a live price and an interactive chart covering 19+ years of daily price history, plus key valuation metrics. ChartRow also publishes JAZZ's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full JAZZ financial statements →
